A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator (2019)
Attributed to:
Cyclic oligoadenylate signalling - a new type of antiviral response
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/582114
Publication URI: http://dx.doi.org/10.1101/582114
Type: Preprint